SEEL Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Seelos Therapeutics Inc

Watchlist Manager

Watchlist

Price: 0.39 USD -27.79% Market Closed

Market Cap: $83.6k

	Seelos Therapeutics Inc OTC:SEEL	US
B	Burckhardt Compression Holding AG XBER:B5H	CH
E	Emerson Electric Co XBER:EMR	US
	Markel Corp NYSE:MKL	US
	Oppein Home Group Inc SSE:603833	CN
G	Great Panther Mining Ltd LSE:0R0D	CA

Profitability Summary

Seelos Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-1 480%

Negative 3Y Average Operating Margin

-2 671%

Operating Margin is Increasing

-4 856% > -1 480%

Exceptional Net Margin

203%

Negative 3Y Average Net Margin

-2 657%

Net Margin is Increasing

-7 097% > 203%

Negative Free Cash Flow Margin

-659%

Negative 3Y Average Free Cash Flow Margin

-1 693%

Free Cash Flow Margin is Increasing

-3 533% > -659%

Negative ROE

-11%

Exceptional 3Y Average ROE

Exceptional 3Y Average ROIC

1 399%

ROIC is Increasing

-1 274% > 426%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.